文献速递肾小球疾病慢性肾脏病肾血管病与高血压

狼疮性肾炎与其他慢性肾脏病病因的长期结局比较

Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies.
PubMed 文献 · Kidney Int Rep · 2024-10-28

基于瑞典肾脏登记(2006-2021)数据,比较狼疮性肾炎相关慢性肾脏病(LN-CKD)与原发性肾小球疾病(PGD)及其他CKD病因的长期结局。LN-CKD患者5年肾脏替代治疗风险与Other-CKD相似(22%),低于PGD(37%),但死亡和主要不良心血管事件风险高于PGD,与Other-CKD相当。

要点

  • LN-CKD的5年KRT绝对风险为22%,与Other-CKD相似,低于PGD的37%。
  • 相比PGD,LN-CKD死亡风险更高(HR 1.63),MACE风险更高(HR 1.65)。
  • LN-CKD与Other-CKD的不良事件发生率无差异。

核心结论

  • LN-CKD患者KRT风险低于PGD-CKD,但死亡和MACE风险更高,达到高心血管负担Other-CKD患者的风险量级。

研究设计与样本

  • 基于瑞典肾脏登记(2006-2021)数据的比较性队列研究,纳入LN-CKD 317例、PGD 2296例、Other-CKD 34778例,中位随访6.2年。

主要发现

  • LN-CKD的死亡和MACE绝对风险介于Other-CKD与PGD之间。
  • LN-CKD的5年KRT绝对风险为22%,与Other-CKD相似,低于PGD的37%。
  • 多变量分析中,相比PGD,LN-CKD死亡HR为1.63(95%CI 1.32-2.02),MACE HR为1.65(95%CI 1.31-2.08),KRT HR为0.81(95%CI 0.64-1.02)。
  • LN-CKD与Other-CKD的不良事件发生率无差异。

临床怎么用

  • 对中晚期LN-CKD患者应重视心血管事件预防,因其死亡和MACE风险与高心血管负担人群相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Little is known regarding the comparison of cardiovascular and kidney outcomes between lupus nephritis (LN) and other etiologies of chronic kidney disease (CKD). METHODS: Using data from the Swedish Renal Registry (2006-2021), we compared long-term outcomes between patients with LN-CKD and patients with CKD due to primary glomerular diseases (PGD) and other CKD causes (Other-CKD, mainly diabetes and nephroangiosclerosis). Adjusted hazard ratios (HRs) of mortality, major adverse cardiovascular events (MACE) and kidney replacement therapy (KRT) were estimated using Cox proportional hazard models. RESULTS: At baseline, LN (n = 317, 61 years, 76% women) and PGD (n = 2296, 57 years, 30% women) had better kidney function and lower prevalence of cardiovascular disease than the Other-CKD (n = 34,778, 75 years, 36% women). The median follow-up was 6.2 (3.3-9.8) years. The absolute risks of death and MACE in LN-CKD were intermediate between those of Other-CKD and PGD. The 5-year absolute KRT risk of LN-CKD was similar to Other-CKD's risk (22%) and lower than in PGD (37%). In multivariable analysis, as compared to PGD, the rates of death and MACE in LN-CKD were higher (HR: 1.63 [95% confidence interval: 1.32-2.02] and 1.65 [1.31-2.08]), whereas the rate of KRT tended to be lower (0.81 [0.64-1.02]). In contrast, the rate of adverse events was not different between LN-CKD and Other-CKD. CONCLUSION: Although patients with LN-CKD had a lower risk of KRT than PGD-CKD, they exhibited higher risk of death and MACE, reaching the risk magnitude of patients with high cardiovascular burden (Other-CKD). Our findings may inform decisions about prevention of cardiovascular events in patients with moderate and advanced LN-CKD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Chrysostomou C, Faustini F, Gunnarsson I, et al. Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies. Kidney Int Rep. 2024. PMID: 39810755. doi:10.1016/j.ekir.2024.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。